Startseite Medizin A statistical basis for harmonization of thyroid stimulating hormone immunoassays using a robust factor analysis model
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

A statistical basis for harmonization of thyroid stimulating hormone immunoassays using a robust factor analysis model

  • Dietmar Stöckl , Katleen Van Uytfanghe , Stefan Van Aelst und Linda M. Thienpont EMAIL logo
Veröffentlicht/Copyright: 22. Februar 2014
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Between-method equivalence ideally is achieved by calibration against an SI-traceable reference measurement procedure. For measurement of thyroid stimulating hormone (TSH), it is unlikely to accomplish this goal in mid-term. Therefore, we investigated a statistical alternative based on a factor analysis (FA) model.

Methods: The FA model was applied to TSH results for 94 samples generated by 14 immunoassays (concentration range: 0.0005–78 mIU/L). The dataset did not fulfill the assumption of a homogeneous sample from an elliptically symmetric distribution, and, therefore, required standardization prior to application of the FA model. As outliers and missing values also occurred, the key quantities of the FA model had to be estimated with a method that can handle these complications. We selected a robust alternating regressions (RAR) method, which replaces in the minimization criterion of the fitting process the squared differences between results xij and model fit x^ij by a weighted absolute difference. The weights are adaptively determined in successive regressions, which down weighs the outliers. The weights for missing values are set to zero.

Results: The quality of the estimated targets was reflected by their central position in the distributions, and description of the relationship between results and targets by a simple two-parameter regression equation with high correlation coefficients and low SDs of the percentage-residuals. Mathematical recalibration eliminated the method differences and improved the between-method CV from 11% to 6%.

Conclusions: RAR applied to a multimethod comparison dataset hampered by outliers and missing values, is fit to the purpose of harmonization.


Corresponding author: Linda M. Thienpont, Laboratory for Analytical Chemistry, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, 9000 Gent, Belgium, Phone: +32 9 2648104, Fax: +32 9 2648198, E-mail:

Acknowledgments

The authors are indebted to the IFCCs Committee for Standardization of Thyroid Functions Test and the partners from the in-vitro diagnostic industry for the inspirational support to conduct this statistical study.

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article. Research support played no role in thestudy design; in the collection, analysis, and interpretationof data; in the writing of the report; or in the decision tosubmit the report for publication.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Miller WG, Myers GL, Gantzer ML, Kahn SE, Schönbrunner ER, Thienpont LM, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011;57:1108–17.10.1373/clinchem.2011.164012Suche in Google Scholar PubMed

2. Joint Committee for Traceability in Laboratory Medicine (JCTLM) Database of higher-order reference materials, measurement methods/procedures and services. Available from: http://www.bipm.org/jctlm/. Accessed 31 July, 2013.Suche in Google Scholar

3. Thienpont LM, Van Houcke SK. Traceability to a common standard for protein measurements by immunoassay for in-vitro diagnostic purposes. Clin Chim Acta 2010;411:2058–61.10.1016/j.cca.2010.09.001Suche in Google Scholar PubMed

4. Lawton WH, Sylvestre EA, Young-Ferraro BJ. Statistical comparison of multiple analytic procedures: application to clinical chemistry. Technometrics 1979;21:397–409.10.1080/00401706.1979.10489809Suche in Google Scholar

5. Carey RN, Wold S, Westgard JO. Principal component analysis: an alternative to “referee” methods in method comparison studies. Anal Chem 1975;47:1824–9.10.1021/ac60361a037Suche in Google Scholar PubMed

6. Rymer JC, Sabatier R, Daver A, Bourleaud J, Assicot M, Bremond J, et al. A new approach for clinical biological assay comparison and standardization: application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits. Clin Chem 1999;45:869–81.Suche in Google Scholar

7. Van Houcke SK, Van Aelst S, Van Uytfanghe K, Thienpont LM. Harmonization of immunoassays to the all-procedure trimmed mean – proof of concept by use of data from the insulin standardization project. Clin Chem Lab Med 2013;51:e103–5.10.1515/cclm-2012-0661Suche in Google Scholar PubMed

8. Miller WG, Thienpont LM, Van Uytfanghe K, Clark PM, Lindstedt P, Nilsson G, et al. Toward standardization of insulin immunoassays. Clin Chem 2009;55:1011–8.10.1373/clinchem.2008.118380Suche in Google Scholar PubMed

9. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, et al. Report of the IFCC Working Group for Standardization of Thyroid Function Tests, Part 1: Thyroid-stimulating hormone. Clin Chem 2010;56:902–11.10.1373/clinchem.2009.140178Suche in Google Scholar PubMed

10. Wold H. Nonlinear estimation by iterative least squares procedures. In: David FN, editor. Research papers in statistics: Festschrift for Jerzy Neyman. London: Wiley, 1966;411–44.Suche in Google Scholar

11. Gabriel KR, Zamir S. Lower rank approximation of matrices by least squares with any choice of weights. Technometrics 1979;21:489–98.10.1080/00401706.1979.10489819Suche in Google Scholar

12. Croux C, Filzmoser P, Pison G, Rousseeuw PJ. Fitting multiplicative models by robust alternating regressions. Statist Comput 2003;13:23–36.10.1023/A:1021979409012Suche in Google Scholar

13. Hubert M, Rousseeuw PJ, Van Aelst S. High-breakdown robust multivariate methods. Stat Sci 2008;23:92–119.10.1214/088342307000000087Suche in Google Scholar

14. Westgard QC. Desirable specifications for total error, imprecision, and bias derived from biologic variation. Available from: http://www.westgard.com/biodatabase1.htm. Accessed 31 July, 2013.Suche in Google Scholar

15. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: http://www.R-project.org/. Accessed 31 July, 2013.Suche in Google Scholar

16. Chu H, Chen S, Louis TA. Random effects models in a meta-analysis of the accuracy of two diagnostic tests without a gold standard. J Am Stat Assoc 2009;104:512–23.10.1198/jasa.2009.0017Suche in Google Scholar PubMed PubMed Central

17. Joo DJ, Jung I, Kim MS, Huh KH, Kim H, Choi JS, et al. Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation. Transplan Proc 2010;42:4137–40.10.1016/j.transproceed.2010.09.088Suche in Google Scholar PubMed

18. Rose CE, Romero-Steiner S, Burton RL, Carlone GM, Goldblatt D, Nahm MH, et al. Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera. Clin Vaccine Immunol 2011;18:135–42.10.1128/CVI.00370-10Suche in Google Scholar PubMed PubMed Central

Received: 2013-12-2
Accepted: 2014-1-27
Published Online: 2014-2-22
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Diagnosis of diabetes mellitus: reiterated responsibilities for the clinical laboratory
  4. Review
  5. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis
  6. Opinion Papers
  7. Harmonization of quality indicators in laboratory medicine. A preliminary consensus
  8. Cardiac biomarkers and risk assessment in patients undergoing major non-cardiac surgery: time to revise the guidelines?
  9. General Clinical Chemistry and Laboratory Medicine
  10. A statistical basis for harmonization of thyroid stimulating hormone immunoassays using a robust factor analysis model
  11. Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) target
  12. Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine
  13. Automated indirect immunofluorescence microscopy enables the implementation of a quantitative internal quality control system for anti-nuclear antibody (ANA) analysis
  14. Peripheral blood lymphocytes from patients with bipolar disorder demonstrate apoptosis and differential regulation of advanced glycation end products and S100B
  15. Coefficient of energy balance, a new parameter for basic investigation of the cerebrospinal fluid
  16. Interconversion of stone composition profiles from two recurrent stone episodes in stone formers
  17. Reference Values
  18. Complete blood count reference intervals and age- and sex-related trends of North China Han population
  19. Cancer Diagnostics
  20. The quantification of HER2 and MYC gene fragments in cell-free plasma as putative biomarkers for gastric cancer diagnosis
  21. Cardiovascular Diseases
  22. Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference
  23. Interleukin-6 receptor Asp358Ala gene polymorphism is associated with plasma C-reactive protein levels and severity of aortic valve stenosis
  24. Diabetes
  25. Stability of glucose in plasma with different anticoagulants
  26. Plasma glucose measurement in diabetes: impact and implications of variations in sample collection procedures with a focus on the first hour after sample collection
  27. Changing from glucose to HbA1c for diabetes diagnosis: predictive values of one test and importance of analytical bias and imprecision
  28. System accuracy evaluation of systems for point-of-care testing of blood glucose: a comparison of a patient-use system with six professional-use systems
  29. Letter to the Editors
  30. Reply to the article entitled “Identification of an 18 bp deletion in the TWIST1 gene by CO-amplification at lower denaturation temperature-PCR (COLD-PCR) for non-invasive prenatal diagnosis of craniosynostosis: first case report” by Galbiati et al., Clin Chem Lab Med 2014;52(4):505–9
  31. Further considerations concerning non-invasive prenatal diagnosis of craniosynostosis based on the identification of an 18 bp deletion in the TWIST1 gene by COLD-PCR
  32. Sensible use of laboratory testing requires active laboratory involvement
  33. Digoxin overdose – an accurate method for determining free digoxin concentrations on general chemistry analysers post DigiFab treatment
  34. Method-specific differences in β-isomerised carboxy-terminal cross-linking telopeptide of type I collagen and procollagen type I amino-terminal propeptide using two fully automated immunoassays
  35. Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer
  36. Evaluation of Calfast® immunochromatographic quantitative assay for the measurement of calprotectin in faeces
  37. Measurement error in estimated average glucose: a novel approach
  38. Feasibility of an EQAS for HbA1c in Italy using fresh blood samples
  39. Congress Abstracts
  40. 5th Annual International Symposium on Kallikreins and Kallikrein-Related Peptidases
Heruntergeladen am 7.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2013-1038/pdf
Button zum nach oben scrollen